F3 and neoplasm: To investigate the utility of CD142 to isolate mutant cells from heterogeneous primary desmoid tumor cultures, we conducted CD142-based flow cytometry and FACS of three primary cultures with a known mutation and the two primary cultures in which we did not detect any mutations in CTNNB1 using Sanger sequencing.